Pricing Log in Create free account

Corbus Pharmaceuticals Holdings, Inc. (CRBP) vs XBiotech Inc. (XBIT)

Corbus Pharmaceuticals Holdings, Inc. and XBiotech Inc. are both Biotechnology companies. Corbus Pharmaceuticals Holdings, Inc. and XBiotech Inc. are of similar size ($57.0M and $55.3M). Corbus Pharmaceuticals Holdings, Inc. grew revenue faster over the last twelve months: −73.7% against −78.2%. Across the 13 metrics below, XBiotech Inc. leads on 8 and Corbus Pharmaceuticals Holdings, Inc. on 5.

Valuation

Metric CRBP XBIT Biotechnology median
P/E n/m n/m 10.60
P/S 38.44 14.29 9.40
P/B 0.58 0.45 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.34 0.90 0.66
EV/Sales (23.77) (10.46) 9.02
Earnings yield (202.95%) (78.72%) (32.88%)
Free cash flow yield (146.45%) (71.50%) (23.13%)

Profitability

Metric CRBP XBIT Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (95.58%) (29.94%) (51.96%)
Return on assets (80.85%) (28.90%) (46.06%)
Return on invested capital 0.00% (159.18%) 0.00%

Growth

Metric CRBP XBIT Biotechnology median
Revenue growth (TTM) (73.69%) (78.20%) 6.76%
EPS growth (last fiscal year) (60.33%) (18.25%) 29.88%
Revenue growth, 5-year CAGR (14.34%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRBP XBIT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.71 33.15 4.97
Net debt to EBITDA 1.90 2.33 1.01

Dividend

Metric CRBP XBIT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CRBP XBIT Biotechnology median
Market cap 55.32m 57.01m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack